Literature DB >> 18457011

Expanding role for the apelin/APJ system in physiopathology.

C Carpéné1, C Dray, C Attané, P Valet, M P Portillo, I Churruca, F I Milagro, I Castan-Laurell.   

Abstract

Apelin is a bioactive peptide known as the ligand of the G protein-coupled receptor APJ. Diverse active apelin peptides exist under the form of 13, 17 or 36 amino acids, originated from a common 77-amino-acid precursor. Both apelin and APJ mRNA are widely expressed in several rodent and human tissues and have functional effects in both the central nervous system and peripheral tissues. Apelin has been shown to be involved in the regulation of cardiovascular functions, fluid homeostasis, vessel formation and cell proliferation. More recently, apelin has been described as an adipocyte-secreted factor (adipokine), up-regulated in obesity. By acting as circulating hormone or paracrine factor, adipokines are involved in physiological regulations (fat depot development, energy storage, metabolism or eating behavior) or in the promotion of obesity-associated disorders (type 2 diabetes and cardiovascular dysfunctions). In this regard, expression of apelin gene in adipose tissue is increased by insulin and TNFalpha. This review will consider the main roles of apelin in physiopathology with particular attention on its role in energy balance regulation and in obesity-associated disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18457011

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  32 in total

1.  Modulation of the apelin/APJ system in heart failure and atherosclerosis in man.

Authors:  Sarah L Pitkin; Janet J Maguire; Rhoda E Kuc; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 2.  Apelin, diabetes, and obesity.

Authors:  Isabelle Castan-Laurell; Cédric Dray; Camille Attané; Thibaut Duparc; Claude Knauf; Philippe Valet
Journal:  Endocrine       Date:  2011-08       Impact factor: 3.633

Review 3.  The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives.

Authors:  Gerasimos Socrates Christodoulatos; Nikolaos Spyrou; Jona Kadillari; Sotiria Psallida; Maria Dalamaga
Journal:  Curr Obes Rep       Date:  2019-12

4.  The protective effect of apelin against water-immersion and restraint stress-induced gastric damage.

Authors:  V Nimet Izgüt-Uysal; Burcu Gemici; Ilknur Birsen; Nuray Acar; Ismail Üstünel
Journal:  J Physiol Sci       Date:  2014-05-06       Impact factor: 2.781

5.  Increased bone mass in mice lacking the adipokine apelin.

Authors:  Lalita Wattanachanya; Wei-Dar Lu; Ramendra K Kundu; Liping Wang; Marcia J Abbott; Dylan O'Carroll; Thomas Quertermous; Robert A Nissenson
Journal:  Endocrinology       Date:  2013-04-12       Impact factor: 4.736

Review 6.  Classic and Novel Adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies.

Authors:  Nikolaos Spyrou; Konstantinos I Avgerinos; Christos S Mantzoros; Maria Dalamaga
Journal:  Curr Obes Rep       Date:  2018-12

7.  Plasma apelin level in patients with restless legs syndrome and its association with periodic leg movements.

Authors:  Selda Korkmaz; Murat Aksu; Gulden Baskol
Journal:  Sleep Breath       Date:  2016-05-19       Impact factor: 2.816

Review 8.  Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.

Authors:  Giovanni Anfossi; Isabella Russo; Gabriella Doronzo; Alice Pomero; Mariella Trovati
Journal:  Mediators Inflamm       Date:  2010-06-28       Impact factor: 4.711

Review 9.  New insights about the putative role of myokines in the context of cardiac rehabilitation and secondary cardiovascular prevention.

Authors:  Domenico Di Raimondo; Giuseppe Miceli; Gaia Musiari; Antonino Tuttolomondo; Antonio Pinto
Journal:  Ann Transl Med       Date:  2017-08

10.  Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus.

Authors:  Federico Soriguer; Lourdes Garrido-Sanchez; Sara Garcia-Serrano; Jose M Garcia-Almeida; Juan Garcia-Arnes; Francisco J Tinahones; Eduardo Garcia-Fuentes
Journal:  Obes Surg       Date:  2009-09-15       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.